Doris Finkelmeier

1.3k total citations
17 papers, 1.1k citations indexed

About

Doris Finkelmeier is a scholar working on Immunology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Doris Finkelmeier has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Epidemiology. Recurrent topics in Doris Finkelmeier's work include Immune Response and Inflammation (4 papers), Nuclear Receptors and Signaling (4 papers) and Macrophage Migration Inhibitory Factor (4 papers). Doris Finkelmeier is often cited by papers focused on Immune Response and Inflammation (4 papers), Nuclear Receptors and Signaling (4 papers) and Macrophage Migration Inhibitory Factor (4 papers). Doris Finkelmeier collaborates with scholars based in Germany, Egypt and United States. Doris Finkelmeier's co-authors include Anke Burger‐Kentischer, Jürgen Bernhagen, Robert Kleemann, Georg Geiger, Herwig Brunner, Steffen Rupp, Matthias Grell, Thierry Roger, Aphrodite Kapurniotu and Franz‐Josef Johannes and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Doris Finkelmeier

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris Finkelmeier Germany 14 656 291 228 109 83 17 1.1k
Sutapa Sinha United States 20 248 0.4× 36 0.1× 380 1.7× 14 0.1× 47 0.6× 43 908
Szczepan Józefowski Poland 16 385 0.6× 25 0.1× 208 0.9× 19 0.2× 121 1.5× 26 698
Michio Shimamura Japan 17 600 0.9× 31 0.1× 237 1.0× 14 0.1× 99 1.2× 54 961
Gérard Redziniak France 17 265 0.4× 25 0.1× 169 0.7× 31 0.3× 48 0.6× 31 694
T. ESKELAND Norway 20 423 0.6× 31 0.1× 316 1.4× 14 0.1× 53 0.6× 38 937
Hongmei Xu China 11 602 0.9× 15 0.1× 335 1.5× 21 0.2× 82 1.0× 13 1.0k
D. Resnick United States 8 630 1.0× 34 0.1× 416 1.8× 9 0.1× 112 1.3× 8 1.2k
Tomomi Hashidate Japan 9 895 1.4× 35 0.1× 938 4.1× 10 0.1× 58 0.7× 10 1.4k
Bruna Araújo David Brazil 16 286 0.4× 27 0.1× 171 0.8× 8 0.1× 177 2.1× 28 825

Countries citing papers authored by Doris Finkelmeier

Since Specialization
Citations

This map shows the geographic impact of Doris Finkelmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Finkelmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Finkelmeier more than expected).

Fields of papers citing papers by Doris Finkelmeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Finkelmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Finkelmeier. The network helps show where Doris Finkelmeier may publish in the future.

Co-authorship network of co-authors of Doris Finkelmeier

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Finkelmeier. A scholar is included among the top collaborators of Doris Finkelmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Finkelmeier. Doris Finkelmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Finkelmeier, Doris, et al.. (2024). A novel three-dimensional Nrf2 reporter epidermis model for skin sensitization assessment. Toxicology. 503. 153743–153743. 3 indexed citations
2.
Zayed, Ahmed, et al.. (2023). Characterization and Cytotoxic Activity of Microwave-Assisted Extracted Crude Fucoidans from Different Brown Seaweeds. Marine Drugs. 21(1). 48–48. 22 indexed citations
3.
Finkelmeier, Doris, et al.. (2022). Human-Based Immune Responsive In Vitro Infection Models for Validation of Novel TLR4 Antagonists Identified by Computational Discovery. Microorganisms. 10(2). 243–243. 5 indexed citations
4.
Gege, Christian, Fernando Bravo, Nadja Uhlig, et al.. (2021). A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections. Science Translational Medicine. 13(598). 38 indexed citations
5.
Zayed, Ahmed, Thomas Hahn, Doris Finkelmeier, et al.. (2019). Phenomenological investigation of the cytotoxic activity of fucoidan isolated from Fucus vesiculosus. Process Biochemistry. 81. 182–187. 23 indexed citations
6.
Mezan, Shaul, Andreas Kühbacher, Doris Finkelmeier, et al.. (2018). Computationally Designed Bispecific MD2/CD14 Binding Peptides Show TLR4 Agonist Activity. The Journal of Immunology. 201(11). 3383–3391. 16 indexed citations
7.
Kühbacher, Andreas, Philip Stevens, Christian Grumaz, et al.. (2017). Central Role for Dermal Fibroblasts in Skin Model Protection against Candida albicans. The Journal of Infectious Diseases. 215(11). 1742–1752. 40 indexed citations
8.
Rupp, Steffen, et al.. (2016). Computational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads. Journal of Chemical Information and Modeling. 56(9). 1835–1846. 26 indexed citations
9.
Zayed, Ahmed, Kai Muffler, Thomas Hahn, et al.. (2016). Physicochemical and Biological Characterization of Fucoidan from Fucus vesiculosus Purified by Dye Affinity Chromatography. Marine Drugs. 14(4). 79–79. 77 indexed citations
10.
Finkelmeier, Doris, et al.. (2013). An In Vitro HSV-1 Reactivation Model Containing Quiescently Infected PC12 Cells. SHILAP Revista de lepidopterología. 2(4). 250–257. 8 indexed citations
11.
Burger‐Kentischer, Anke, Doris Finkelmeier, Petra Keller, et al.. (2011). A Screening Assay Based on Host-Pathogen Interaction Models Identifies a Set of Novel Antifungal Benzimidazole Derivatives. Antimicrobial Agents and Chemotherapy. 55(10). 4789–4801. 16 indexed citations
12.
Bauer, Jörg, Anke Burger‐Kentischer, Doris Finkelmeier, et al.. (2011). High-Throughput-Screening-Based Identification and Structure–Activity Relationship Characterization Defined (S)-2-(1-Aminoisobutyl)-1-(3-chlorobenzyl)benzimidazole as a Highly Antimycotic Agent Nontoxic to Cell Lines. Journal of Medicinal Chemistry. 54(19). 6993–6997. 20 indexed citations
13.
Burger‐Kentischer, Anke, et al.. (2010). A new cell-based innate immune receptor assay for the examination of receptor activity, ligand specificity, signalling pathways and the detection of pyrogens. Journal of Immunological Methods. 358(1-2). 93–103. 31 indexed citations
14.
Burger‐Kentischer, Anke, Heike Göbel, Robert Kleemann, et al.. (2005). Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis. 184(1). 28–38. 110 indexed citations
15.
Burger‐Kentischer, Anke, Doris Finkelmeier, Michael Thiele, et al.. (2005). Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif. FEBS Letters. 579(7). 1693–1701. 36 indexed citations
16.
Nguyen, Mai Tuyet, Hongqi Lue, Robert Kleemann, et al.. (2003). The Cytokine Macrophage Migration Inhibitory Factor Reduces Pro-Oxidative Stress-Induced Apoptosis. The Journal of Immunology. 170(6). 3337–3347. 115 indexed citations
17.
Kleemann, Robert, Angelika Haußer, Georg Geiger, et al.. (2000). Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature. 408(6809). 211–216. 493 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sutapa Sinha Breakdown of academic impact, for papers by Szczepan Józefowski Breakdown of academic impact, for papers by Michio Shimamura Breakdown of academic impact, for papers by Gérard Redziniak Breakdown of academic impact, for papers by T. ESKELAND Breakdown of academic impact, for papers by Hongmei Xu Breakdown of academic impact, for papers by D. Resnick Breakdown of academic impact, for papers by Tomomi Hashidate Breakdown of academic impact, for papers by Bruna Araújo David
Rankless by CCL
2026